trending Market Intelligence /marketintelligence/en/news-insights/trending/eloum1r8nfdvkmy5g7ad6g2 content esgSubNav
In This List

Audentes Therapeutics names president/COO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Audentes Therapeutics names president/COO

Audentes Therapeutics Inc. promoted Natalie Holles to president and COO.

Holles was senior vice president and COO.

In the new role, she will oversee the day-to-day operations of the company, including research, development, manufacturing, program management and corporate development.

Holles joined Audentes in 2015, bringing 15 years of corporate development, strategic planning and commercial experience gained in a range of therapeutic areas and with a focus on rare diseases, Audentes said in a statement.